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Background: Type 2 diabetes is a major health problem in many countries including India. Yoga may be an
effective type 2 diabetes prevention strategy in India, particularly given its cultural familiarity.
Methods: This was a parallel, randomized controlled pilot study to collect feasibility and preliminary efficacy data
on yoga for diabetes risk factors among people at high risk of diabetes. Primary outcomes included: changes in
BMI, waist circumference, fasting blood glucose, postprandial blood glucose, insulin, insulin resistance, blood
pressure, and cholesterol. We also looked at measures of psychological well-being including changes in depression,
anxiety, positive and negative affect and perceived stress. Forty-one participants with elevated fasting blood glucose
in Bangalore, India were randomized to either yoga (n = 21) or a walking control (n = 20). Participants were asked to
either attend yoga classes or complete monitored walking 3–6 days per week for eight weeks. Randomization and
allocation was performed using computer-generated random numbers and group assignments delivered in sealed,
opaque envelopes generated by off-site study staff. Data were analyzed based on intention to treat.
Results: This study was feasible in terms of recruitment, retention and adherence. In addition, yoga participants had
significantly greater reductions in weight, waist circumference and BMI versus control (weight −0.8 ± 2.1 vs. 1.4 ±
3.6, p = 0.02; waist circumference −4.2 ± 4.8 vs. 0.7 ± 4.2, p < 0.01; BMI −0.2 ± 0.8 vs. 0.6 ± 1.6, p = 0.05). There were
no between group differences in fasting blood glucose, postprandial blood glucose, insulin resistance or any other
factors related to diabetes risk or psychological well-being. There were significant reductions in systolic and diastolic
blood pressure, total cholesterol, anxiety, depression, negative affect and perceived stress in both the yoga
intervention and walking control over the course of the study.
Conclusion: Among Indians with elevated fasting blood glucose, we found that participation in an 8-week yoga
intervention was feasible and resulted in greater weight loss and reduction in waist circumference when compared
to a walking control. Yoga offers a promising lifestyle intervention for decreasing weight-related type 2 diabetes risk
factors and potentially increasing psychological well-being.
Trial registration: ClinicalTrials.gov Identified NCT00090506.
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Type 2 diabetes mellitus (T2DM) is a major global health
problem with a prevalence of 366 million in 2011 that
is projected to increase by 51%, reaching 552 million by
2030 [1,2]. India follows this global trend with a preva-
lence of 60 million in 2011 that is projected to increase by* Correspondence: mcdermottk@ocim.ucsf.edu
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article, unless otherwise stated.63%, reaching 98 million by 2030 [1]. Factors contributing
to the high prevalence of T2DM in India include genetic
predisposition exacerbated by environmental factors in-
cluding increasing prosperity and urbanization resulting in
increased abdominal obesity and insulin resistance [3,4].
In India, there is also a high prevalence of prediabetes,
with elevated fasting blood glucose (FBG) in the range of
5.6-6.9 mmol/L [3,5]. Individuals with prediabetes are at
an increased risk of developing T2DM (FBG ≥7 mmol/L);
5-10% will develop T2DM within one year, 25% withinntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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of high risk individuals with at least three of the following
five risk factors: elevated FBG, elevated blood pressure, low
high-density lipoproteins (HDL), elevated triglycerides and
abdominal obesity [7]. Lower cutpoints for waist circumfer-
ence plus additional criteria for body mass index (BMI) and
truncal subcutaneous fat have been recommended as cri-
teria for metabolic syndrome in the Indian population
based on their predisposition for T2DM and cardiovascular
disease (CVD) [4,8].
Lifestyle interventions including exercise have been ef-
fective in offsetting T2DM complications and the progres-
sion from prediabetes or metabolic syndrome to T2DM
[6,9-11]. By modifying muscle fibers and enhancing beta
cell functions, exercise can optimize insulin sensitivity and
improve glucose intolerance [12,13]. Thus, exercise may
be particularly effective in earlier disease stages and has
been associated with a 30% reduction in metabolic syn-
drome [14] and a T2DM risk reduction of 63-65% in
people with prediabetes [15].
In India there is a rich history of using yoga to manage
T2DM [3]. Yoga is a mind/body practice based on trad-
itional Indian philosophy, often incorporating three major
components: held or sequences of physical postures,
breathing exercises and meditation [16,17]. Yoga’s energy
expenditure is similar to other low to moderate exercise
[18-20] and a recent review found yoga had beneficial out-
comes similar to those of moderate exercise in populations
with T2DM [21]. Subsequent to the current pilot study,
members of our group completed a trial of n = 277 partici-
pants in Bangalore, India with T2DM, comparing a yoga
program aimed at T2DM management with an exercise
program of comparable intensity. In that study yoga was
similar to exercise in terms of reducing FBG, hemoglobin
A1c (HbA1c), triglycerides, total cholesterol and very low-
density lipoproteins (VLDL) [22]. Evidence suggesting that
yoga may also be an effective preventive practice in high
risk populations, such as with prediabetes and/or metabolic
syndrome, is also accumulating [23]. Investigators recently
concluded a large randomized controlled trial of
restorative yoga vs. stretching for participants with meta-
bolic syndrome and found that the yoga group had
significant reductions in FBG that were sustained at
12 months [24].
Additional benefits of yoga include improved exercise-
related self-efficacy [25] quality of life [26] and mood
[27,28] all of which are important factors in maintenance
of lifestyle behavior change. Yoga also may have a different
effect on the sympathetic nervous system (SNS) and
hypothalamus-pituitary-adrenal (HPA) axis response to
stress compared to other types of exercise. Where other
exercise can stimulate the SNS/HPA axis, yoga may be
down regulating it, shifting to parasympathetic dominance
of the stress response [21,23]. In Nagarathna et al., authorsfound that yoga was superior to exercise at decreasing the
need for oral hypoglycemia medications, decreasing low-
density lipoproteins (LDL) and increasing HDL, suggest-
ing a benefit associated with yoga in addition to that of
just increasing exercise [22].
The current pilot study compares yoga to a walking con-
trol among Indians in Bangalore over an 8-week interven-
tion period. This study is a product of an international
collaboration to share areas of expertise between the Swami
Vivekananda Yoga Anusandhana Samsthana (SVYASA) in
Bangalore, India and the Osher Center for Integrative
Medicine (OCIM) at the University of California, San
Francisco (UCSF). The pilot study aimed to establish feasi-
bility based on meeting recruitment, retention and adher-
ence goals and to collect preliminary efficacy data on
changes in T2DM risk factors and psychological well-being.
Methods
Study design and participants
This was a 1:1 randomized controlled pilot study con-
ducted in Bangalore, India. The study was reviewed and
approved by the research ethics committees at SVYASA
and UCSF. Written, informed consent was obtained from
all participants. Figure 1 depicts a flow diagram of study
screening, enrollment and analysis. Participants were re-
cruited over one week, (October 24, 2004 – November 1,
2004) using advertisements placed in primary care and
diabetes clinics, as well as strategic locations throughout
the city. Advertisements invited individuals with a first-
degree relative with T2DM and interest in participating in
a yoga program to contact the study staff to schedule a
screening visit. Individuals were asked to come to up to
two screening visits. The first visit evaluated FBG using a
glucometer and finger stick capillary whole blood. Those
with elevated FBG (≥5.6 mmol/L) at the first visit were in-
vited back for a second screening visit. During the second
screening visit the glucometer assessment of FBG was re-
peated to confirm eligibility and an oral glucose tolerance
test (OGTT) was performed. The OGTT used a standard
75 gm glucose load dissolved in 300 ml of water ingested
over 5 minutes. Glucose was then measured in laboratory as-
sessments of venous blood. OGTT between 7.8-11 mmol/L
was in the eligible range. Sixteen percent of participants did
not return for the OGTT two-hour blood draw. Because
all of these participants had a second FBG measure, the
second FBG was used for screening purposes rather than
the OGTT.
In addition to having two screening FBG ≥5.6 mmol/L,
inclusion criteria for this study also included: 1) a first-
degree relative with T2DM; 2) age between 30–65 years;
and, 3) willingness to participate in an 8-week yoga pro-
gram. Exclusion criteria included: 1) an inability to provide
informed consent; 2) taking medications associated with
insulin resistance (e.g. glucocorticoids, thiazide diuretics,
(n=250) 
Normal FBG < 5.6 mmol/L (n=148)
Did not return for second screen (n=16)
Normal, FBG < 5.6 mmol/L (n=39)
Eligible but not consented (n=6)
Walking control (n=20)Yoga intervention (n=21)







Screen 2: FBG and 75mg OGTT,
 venous blood (n=86)
Figure 1 Flow diagram of study enrollment.
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treatment with diabetes medications; 4) active liver disease
(with AST or ALT > 3 times the upper limit of normal); 5)
anemia with hemoglobin < 85 g/L; 6) pregnant or plans to
become pregnant during the course of the study; 7) recent
major trauma or surgery that would interfere with partici-
pation; and 8) inability to speak either English or Kannada
(the local language in Bangalore). Six participants with
borderline FBG screening levels were mistakenly enrolled
in the study and randomized. These participants are in-
cluded in the main intention to treat analysis (ITT), but are
excluded in the per-protocol analysis. The per-protocol
analysis only includes participants meeting the inclusion
criteria of having screening FBG ≥5.6 mmol/L.
Sample size and randomization procedures
Based on this study’s primary feasibility and preliminary
efficacy outcomes, sample size was based on resources
available. Randomization was performed using computer-
generated random numbers and group assignments deliv-
ered in sealed, opaque envelopes generated by off-site
study staff. Participants were not blinded to their group
assignment.
Intervention
The yoga group attended a day long (eight hour) group
counseling session on healthy lifestyle changes with topics
on healthy diet, increasing physical activity and smoking
cessation. Spouses were invited to attend this group coun-
seling session as well. Participants in the interventiongroup were then asked to attend at least three, and up to
six, yoga classes per week over the eight weeks of the study.
Yoga classes were offered on six days of each week. The
classes were held in a community hall and taught by two
registered Ayurveda medical practitioners with Masters
level yoga training from SYVASA. While one instructor
demonstrated postures for the class, the other instructor
adjusted individual participant’s postures or gave them suit-
able alternative postures if necessary.
The yoga intervention was designed to manage glucose
levels by increasing metabolism, reducing stress and facili-
tating a positive outlook. In addition, the classes sought to
connect participants with a sense of responsibility and
control over their health. Each class lasted 75 minutes
total and had the following components: diabetes and stress
management education (10 minutes); breathing exercises
(6 min); loosening exercises (10 min); standing poses
(8 min); supine poses (8 min); prone poses (8 min); sitting
poses (8 min); relaxation/corpse pose (6 min); chanting ex-
ercises and seated meditation (10 min) (see Table 1 for a
more detailed account of postures). The total active time in
poses was approximately 32 minutes. Evidence suggests
that these poses specifically improve muscle metabolism
and stress response [29] and the breathing exercises en-
hance basal metabolic rate [30,31].
The yoga intervention was manualized for this study
and while yoga instructors received detailed instruction
from study staff on how the class was to be conducted, the
yoga classes were not observed by study staff. Participants
were asked to do a home practice if they were unable to
Table 1 Yoga class material and asana sequencing
1. Didactics—10 minutes
Diabetes causes, complications and lifestyle factors
Principles, philosophy, and practices related to a yoga based
lifestyle program
Stress response
Maladaptive behavior and behavior change
Emotion and coping





3. Loosening exercises (any 3)—10 minutes
Jogging
Forward, backward, side bending
Twisting
Pavanamuktasana kriya (Supine knees to chest)
Surya namaskara (3 sun salutations)





Ardhakati chakrasana (Half wheel)
Vrikshasana (Tree)




Pavanamuktasana (Supine knee chest position)
Naukasana (Boat)
7. Prone asana—8 minutes
Bhujangasana I, II , III (Cobra)
Shalabhasana – alternate legs, both (Locust)
Dhanurasana (Bow)
Navasana (Boat)
8. Sitting asana—8 minutes




9. Relaxation Shavasana (Corpse) with guided scan—6 minutes
10 Chanting ‘OM’ monosyllables, primordial sounds in
Indian philosophy
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asked to keep track of each home practice in a daily diary.
Control
The control group attended the same day long (eight
hour) group counseling session on lifestyle changes with
their spouses. The control group was asked to do 30 mi-
nutes of walking plus breaks for rest on three to six days
per week during each of the eight weeks of the study. In-
cluding rest breaks, the total time was approximately
equivalent to the 75 minute yoga class. They were asked
to perform their walking in the park adjacent to the com-
munity hall where the daily yoga classes were held. Two
study volunteers monitored control group participants’ at-
tendance at daily walks in the park.
Measures
Primary feasibility outcomes were determined by percent
of recruitment, retention and adherence goals met. Study
staff blinded to group assignment collected preliminary ef-
ficacy data on blood pressure, weight, and waist circumfer-
ence. Blood pressure was measured as the mean of two
measures taken five minutes apart using a mercury sphyg-
momanometer. Measurement of height (performed only
at baseline) used a standard stadiometer and weight was
measured and duplicated on a calibrated scale. Waist cir-
cumference was measured at the point of minimal circum-
ference at the level of the uppermost lateral border of the
right iliac crest at minimal respiration. In addition to the
FBG and OGTT measurements, blood was also drawn for
a fasting lipid panel and insulin. LDL was calculated dir-
ectly. Fasting insulin was assessed using a Roche Auto-
mated Chemiluminescence analyzer Cobas e411 and Roche
Diagnostic’s insulin kits with an intra assay coefficient of
variation (CV) of 5.4% and inter assay CV of 6%. We used
the calculator available through the Diabetes Trials Unit to
apply version 2 of the homeostasis model assessment
(HOMA) algorithm to calculate insulin resistance [32].
Secondary outcomes related to psychological well-
being included changes in depression, anxiety, positive
affect, negative affect, and perceived stress. Depression
and anxiety were measured using the Hospital Anxiety
and Depression Scale (HADS), a 14-item questionnaire
that avoids measuring symptoms such as fatigue that
may be influenced by diabetes risk factors [33]. Positive
and negative affect were measured using the Positive
and Negative Affect Schedule (PANAS), a 20-item ques-
tionnaire designed to assess high activation positive
affect (e.g. interested, excited, enthusiastic) and high ac-
tivation negative affect (e.g. upset, irritable, ashamed)
[34]. Stress was measured using the Perceived Stress
Scale (PSS), a 10-item instrument asking participants
how often they had positive and negative experiences
related to stress in the prior month [35].
Table 2 Baseline for Yoga and control groups as mean ±
SD unless indicated
Yoga Control
(n = 21) (n = 20)
Age (years) 47.0 ± 9.7 47.2 ± 9.1
Gender (male), n(%) 9 (43) 7 (35)
Diabetes risk factors
Fasting BG (mmol/L) 6.4 ± 0.9 6.7 ± 1.9
Postprandial BG (mmol/L) 8.3 ± 2.6 6.8 ± 1.2
BMI (kg/m2) 28.4 ± 5.3 26.9 ± 3.0
Weight (kg) 69.2 ± 10.8 65.0 ± 7.6
Waist (cm) 92.5 ± 7.3 89.8 ± 7.2
Insulin (pmol/L) 72.3 ± 30.5 57.7 ± 30.1
Insulin resistance 1.4 ± 0.6 1.1 ± 0.6
Systolic (mmHg) 122.9 ± 8.3 127.6 ± 11.4
Diastolic (mmHg) 82.2 ± 9.1 82.3 ± 6.3
LDL (mmol/L) 2.2 ± 0.5 2.2 ± 0.8
Total cholesterol (mmol/L) 5.2 ± 1.2 5.3 ± 0.8
Triglycerides (mmol/L) 1.9 ± 0.8 2.2 ± 1.2
Psychological factors
Anxiety 7.8 ± 5.3 8.3 ± 5.2
Depression 6.0 ± 4.0 6.8 ± 3.8
Positive affect 24.9 ± 7.7 22.4 ± 11.2
Negative affect 15.4 ± 12.7 17.3 ± 11.6
Perceived stress 18.2 ± 5.4 18.0 ± 5.6
BG fasting blood glucose; BMI body mass index; LDL low-density lipoproteins.
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Within group changes and between group treatment ef-
fects associated with participation in the yoga intervention
were evaluated using chi-square tests for categorical data
and paired t-tests, independent sample t-tests, and
Cohen’s d effect sizes (standardized mean difference) for
continuous data. Change scores were calculated as post-
intervention minus baseline measurements. Given the
pilot nature of this study and the relatively small sample
size, we did not have adequate power to detect statistically
significant differences in the case of small or medium ef-
fect sizes. To provide a measure of the observed effect
sizes, we report Cohen’s d for primary and secondary out-
come measures.
Three participants dropped out for personal reasons un-
related to the study. Based on this and the randomization,
we assumed unobserved outcome data was missing at ran-
dom (MAR) and therefore conducted two primary analyses.
First, we excluded dropouts entirely in a complete-case
analysis. With outcomes at one follow-up time point,
complete case is a valid analysis assuming missing out-
comes are MAR [36]. Second, we included dropouts with
their last observation carried forward (LOCF) to include all
randomized participants for ITT. In this case, the LOCF
was the baseline value for the participant who dropped out.
Because participants who dropped out did not complete
the study, we also assumed that there was no change in
their unobserved outcomes. Based on these two assump-
tions, the LOCF analysis provides a more conservative esti-
mate of the within and between group effects [36].
We replicated the complete case, between group com-
parison in a per-protocol analysis, excluding the six partic-
ipants who did not meet the FBG ≥5.6 mmol/L inclusion
criteria. We calculated Pearson’s correlation coefficients
to further explore relationships between T2DM risk fac-
tors and psychological measures. In addition, based on the
wide range of ages among enrolled participants (30–65
years) and the concern that a number of T2DM risk
factors would vary based on age we conducted a sensitivity
analysis to specifically examine whether baseline or change
scores differed by age group. We considered p < 0.05
to be statistically significant and all analyses were con-
ducted using Stata Statistical Software: Release 12. College
Station, TX: StataCorp LP.
Results
Recruitment, retention and adherence goals to determine
feasibility were all met in this pilot study. We retained 94%
of participants, exceeding our goal for feasibility of ≥75%
retention. On average, attendance each week for partici-
pants in the yoga group did not differ from attendance in
the control group (4 ± 0.5 yoga classes per week vs. 3.8 ±
0.5 monitored walks per week, p = 0.13); however, partici-
pants in the yoga group had higher overall attendancecompared to control (p = 0.02). Participants in the yoga
group attended 33.6 ± 4.3 classes over the eight weeks of
the study, which is equivalent to 70% of the maximum of-
fered (six classes per week) and 140% of the minimum re-
quired (three classes per week). This is compared to
attendance in the control group of 30.2 ± 4.3 walking ses-
sions, which is equivalent to 63% of maximum walks of-
fered and 126% of minimum walks required.
The two groups were similar at baseline. In the yoga
group, the mean age was 47.0 ± 9.7 and 43% of participants
were male compared to the control group where the mean
age was 47.2 ± 9.1 and 35% of participants were male
(Table 2). In between group comparisons, yoga participants
had significantly greater reductions in weight, waist circum-
ference and BMI versus the walking control participants
(weight −0.8 ± 2.1 vs. 1.4 ± 3.6, p = 0.02; waist circumfer-
ence −4.2 ± 4.8 vs. 0.7 ± 4.2, p > 0.01; BMI −0.2 ± 0.8 vs.
0.6 ± 1.6, p = 0.05) (Table 3). There were no significant be-
tween group differences in FBG, PPBG, insulin, insulin re-
sistance, blood pressure, cholesterol, or psychological
measures of well-being.
There were, however, significant reductions in blood
pressure and total cholesterol within both groups over the
Table 3 Change scores within yoga and control, and difference between groups with 95% CI and Cohen's d effect size
Yoga Control Diff. (Yoga-Ctrl) P
diff.
Cohen’s
d(n = 20) (n = 18) [95% CI]
Diabetes risk factors
Fasting BG (mmol/L) 0 −0.3 0.3 [−0.5 to 1.1] 0.43 0.27
Postprandial BG (mmol/L)a −0.6 0.1 −0.7 [−2.4 to 0.9] 0.38 0.37
BMI (kg/m2) −0.2 0.6 −0.8 [−1.6 to −0.0] 0.05 0.68
Weight (kg) −0.8 1.4 −2.3 [−4.1 to −0.4] 0.02 0.80
Waist (cm) −4.2* 0.7 −4.9 [−7.9 to −1.9] <0.01 1.11
Systolic (mmHg) −5.3* −5.4* 0.1 [−4.8 to 5.1] 0.95 0.02
Diastolic (mmHg) −5.3* −3.6* −1.7 [−7.6 to 4.1] 0.55 0.20
Insulin (pmol/L) −16.7 4.2 −20.9 [−52.2 to 10.4] 0.19 0.46
Insulin resistance −0.3 0.1 −0.4 [−1.0 to 0.2] 0.17 0.48
LDL (mmol/L) −0.1 0.0 −0.2 [−0.6 to 0.3] 0.47 0.24
Total cholesterol (mmol/L) −0.9* −0.7* −0.2 [−0.9 to 0.6] 0.67 0.15
Triglycerides (mmol/L) −0.1 −0.1 0 [−0.6 to 0.6] 0.95 0.02
Psychological factorsb
Anxiety −2.1* −3.4* 1.3 [−0.8 to 3.4] 0.22 0.42
Depression −2.5* −3.2* 0.7 [−1.7 to 3.2] 0.55 0.21
Positive affect 4.8* 4.6 0.2 [−4.9 to 5.2] 0.95 0.02
Negative affect −5.0* −8.4* 3.4 [−2.3 to 9.0] 0.24 0.41
Perceived stress −5.7* −7.9* 2.2 [−1.3 to 5.8] 0.21 0.43
aPostprandial BG was calculated based on available data, yoga n = 18 control n = 10.
bThree participants were missing data for psychological factors in the control group.
*p < 0.05.




























Figure 2 Pre/post changes in fasting blood glucose.
































Figure 3 Pre/post changes in postprandial blood glucose.
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7, 8, 9, 10, 11, 12 and 13 illustrate within group changes in
T2DM risk factors over time. There were also significant
within group improvements in anxiety, depression, nega-
tive affect and perceived stress in both groups and a sig-
nificant within group improvement in positive affect in
the yoga group (Table 3). For LOCF analysis, the between
group effects were not statistically or substantively differ-
ent from those reported for the complete case analysis.
In the complete case per-protocol analysis, participants
with screening FBG <5.6 mmol/L were excluded (yoga n =























Figure 4 Pre/post changes in body mass index.waist circumference and BMI continued to be significant
and continued to favor the yoga intervention (Table 4).
There were significant within group changes in systolic
blood pressure in both groups, diastolic blood pressure in
the control group and total cholesterol in the yoga inter-
vention (Table 4). The within group changes in psycho-
logical factors in the per-protocol analysis were similar to
those found in the main ITTanalyses (Table 4).
Younger participants had significantly lower LDL and
total cholesterol at baseline (30–39 years 1.6 ± 0.5; 40–49
years 2.2 ± 0.6; 50–59 years 2.6 ± 0.6, ≥60 years 2.39 ± 0.4,






















Figure 5 Pre/post changes in weight.
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we examined correlations between changes in T2DM risk
factors and psychological factors within the yoga group.
We found significant correlations among changes in nega-
tive affect and PPBG (r = 0.49, p = 0.03) and changes in
perceived stress and total cholesterol (r = −0.47, p = 0.04).
We also saw trends for correlations between changes in
depression and PPBG (r = 0.46, p = 0.06); positive affect
and insulin (r = 0.40, p = 0.08); perceived stress and BMI
(r = 0.42, p = 0.06); perceived stress and weight (r = 0.43,
p = 0.06); and positive affect and insulin resistance (r =


















Figure 6 Pre/post changes in waist circumference.Discussion
Both the yoga intervention and walking control groups in
this study exceeded recruitment, retention and adherence
goals, meeting feasibility criteria. We found a significant
decrease in weight, BMI and waist circumference in the
yoga group compared to the walking control, however we
did not see a decrease in FBG, PPBG, insulin, insulin re-
sistance, blood pressure, or cholesterol. We did find sig-
nificant within group decreases in blood pressure and
total cholesterol in both yoga and walking control groups





































Figure 7 Pre/post changes in serum insulin.
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and waist circumference are similar to other reports in
the literature [23,25,37], while the lack of within group
change in FBG is contrary to other reports in similar
high risk populations [23,24]. In the per-protocol ana-
lysis we excluded participants with very low baseline
FBG (those in the normal range) and still saw no change
in FBG. Our null results were similar to another small
study of yoga for high risk individuals (those with a first
degree relative with T2DM plus one of the following: im-
paired FBG, prehypertension, obesity, or abnormal chol-


























Figure 8 Pre/post changes in insulin resistance.lacked power to detect small to medium FBG changes.
Over time, improvements in weight and waist circumfer-
ence could yield additional improvements in FBG and
related measures.
While both groups had statistically significant within
group improvements in measures of psychological well-
being, there were no significant differences between
groups. The control group likely experienced significant
improvement in psychological well-being based on the
walking that they were asked to participate in three to six
days a week. While we had initially hypothesized that the


























Figure 9 Pre/post changes in systolic blood pressure.
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pears to have had an equally powerful effect. There was a
significant within group increase in positive affect in the
yoga group and not in the walking control, however, the
between group difference was not significant. In a recent
large randomized controlled trial, investigators found that
increasing positive affect significantly improved physical
activity maintenance at 12 months suggesting a potential




























Figure 10 Pre/post changes in diastolic blood pressure.There are several important limitations in our study.
First, several participants did not complete the OGTT,
resulting in missing data and limiting our use of OGTT
to establish initial eligibility. Second, six participants
with borderline FBG did not meet the inclusion criteria
of FBG ≥5.6 mmol/L but were mistakenly enrolled and
randomized in this study. By including these participants,
we are not addressing our original research question





























Figure 11 Pre/post changes in low-density lipoproteins.
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http://www.biomedcentral.com/1472-6882/14/212FBG ≥ 5.6 mmol/L. To address this, we also included a
per-protocol analysis excluding the six participants with
FBG <5.6 mmol/L. Third, this study was conducted in
India where yoga originated and continues to maintain
significant cultural influence. This potentially limits the
generalizability of feasibility and adherence findings out-
side of India. Finally, given the modest sample size in this























Figure 12 Pre/post changes in total cholesterol.Conclusions
In summary, our study has several implications for future
investigations of yoga-based interventions for individuals
at high risk of T2DM. Our results indicate that yoga is a
feasible intervention strategy and may help reduce weight,
BMI and waist circumference, three important factors in
T2DM risk. We did not find clear evidence of benefit in
FBG, PPBG, or insulin resistance however, over time, im-



































Figure 13 Pre/post changes in triglycerides.
Table 4 Per-protocola change scores within yoga and control, and difference between groups with 95% CI and Cohen's
d effect size
Yoga Control Diff. (Yoga- Ctrl) P diff. Cohen's D
n = 17 n = 15 [95% CI]
Diabetes risk factors
Fasting BG (mmol/L) 0 −0.5 0.5 [−0.5 to 1.4] 0.32 0.37
Postprandial BG (mmol/L)b −0.4 0.3 −0.7 [−2.8 to 1.4] 0.52 0.32
BMI (kg/m2) −0.2 0.6 −0.9 [−1.8 to 0.1] 0.07 0.69
Weight (kg) −1.0 1.5 −2.5 [−4.8 to −0.3] 0.03 0.83
Waist (cm) −4.9* 0.7 −5.6 [−8.9 to −2.2] <0.01 1.24
Systolic (mmHg) −4.4* −6.5* 2.2 [−3.0 to 7.4] 0.40 0.31
Diastolic (mmHg) −4.6 −3.9* −0.7 [−7.1 to 5.6] 0.82 0.08
Insulin (pmol/L) −14.6 4.1 −18.7 [−54.6 to 17.3] 0.3 0.39
Insulin resistance −0.3 0.1 −0.4 [−1.1 to 0.3] 0.28 0.40
LDL (mmol/L) −0.1 0.2 −0.3 [−0.8 to 0.1] 0.17 0.52
Total cholesterol (mmol/L) −0.9* −0.7 −0.2 [−1.1 to 0.6] 0.58 0.21
Triglycerides (mmol/L) −0.2 −0.3 0.1 [−0.6 to 0.7] 0.83 0.08
Psychological factorsc
Anxiety −1.7* −3.1* 1.4 [−0.7 to 3.6] 0.19 0.50
Depression −2.3* −3.1* 0.8 [−1.9 to 3.4] 0.56 0.22
Positive affect 4.8* 4.7 0.1 [−5.8 to 5.9] 0.99 0.01
Negative affect −4.5* −7.6* 3.0 [−2.4 to 8.5] 0.27 0.42
Perceived stress −6.3* −8.1* 1.8 [−1.7 to 5.3] 0.31 0.38
aSix participants were excluded (yoga n = 3; control n = 3) based on screening FBG <5.6.
bPostprandial BG was calculated based on available data, yoga n = 17 control n = 7.
cOne participant was missing data for psychological factors in the control group.
*p < 0.05.
BG blood glucose; BMI body mass index; LDL low density lipoproteins.
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http://www.biomedcentral.com/1472-6882/14/212additional improvements in these parameters. To further
test the potential benefits of yoga for T2DM prevention,
our results suggest that studies of longer duration and
larger sample size are important.
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